Langerhans cells (LCs) in the epidermis present MHC I and MHC II-restricted antigens thereby priming either CD8 or CD4 T cell immune responses. The genomic programs and transcription factors regulating antigen presentation in LCs remain to be elucidated. We show human LCs are highly efficient in MHC I-antigen cross-presentation but lack the transcription factor IRF8 that is critical in dendritic cells. LC migration from the epidermis enhances their ability to cross-present antigens and is accompanied by the induction of the transcription factor IRF4, whose expression is correlated by scRNA-seq with genes involved in ubiquitin-dependent protein degradation. Chromatin profiling reveals enrichment of EICE and AICE composite DNA binding motifs in regulatory regions of antigen-presentation genes, which can be recognized by IRF4 in conjunction with PU.1 or BATF3 expressed in LCs. Thus, the genomic programming of human LCs including inducible expression of IRF4 with enhanced cross-presentation distinguishes them from conventional dendritic cells.
Introduction
Langerhans cells (LCs) reside in the epidermis as a dense network of immune system sentinels.
They are uniquely specialised at "sensing" the environment by extending dendrites through inter-cellular tight junctions to gain access to the stratum corneum, the outermost part of the skin. LC are highly specialised antigen presenting cells, priming protective immune responses against pathogens encountered via the skin, such as viruses 1-3 , bacteria 4 and fungi 5 . They also promote responses to chemical sensitizers 6, 7 . Their position in the outermost layers of the skin barrier and their capacity to "sense" dangerous perturbations to their environment make them a critical first line of defence in the skin.
LCs were first shown to be highly efficient at presenting exogenous antigens in the context of MHC Class II thereby priming antigen-specific CD4 T cells 8 . More recently, they have also been shown to be capable of efficient cross-presentation in which exogenous antigens are presented on MHC class I, resulting in activation and expansion of antigenspecific effector CD8 T cells 2, 5, 9 . Such cross-presentation becomes particularly important for adaptive immune responses against viruses and also cancerous cells which have evolved immune evasion mechanisms that inactivate DCs 10, 11 .
Activation of skin immune responses requires participation of epidermal cells in collaboration with LCs; cross-talk between the epidermal and immune components being critical. For example, in models of cutaneous viral infection, including vaccinia virus, only skin structural cells support virus replication, while immune cells, including LCs, are infected abortively 12 , necessitating antigen transfer between structural and immune skin components. Cytokine signalling from keratinocytes has been shown to impact LC development and function. Epidermal TGF-β and BMP7 are required for LC development and tolerogenic function in situ [13] [14] [15] and cytokine signalling via thymic stromal lymphopoietin (TSLP) in atopic skin disease polarises skin dendritic cells to prime Th2 and Th22 CD4 T cell responses, while reducing the ability of LCs to cross-prime CD8 T cells [16] [17] [18] [19] . In contrast, TNF-α, a pro-inflammatory cytokine released in skin by a variety of cell types including keratinocytes and fibroblasts as well as dermal macrophages and neutrophils, provides a key component of cutaneous anti-viral immune responses. Numerous reports demonstrate, that keratinocyte-derived TNF-α delivers highly potent signals inducing LC immunogenic function and ability to present antigens 2, [20] [21] [22] [23] and enhances their ability to prime antiviral adaptive immunity 24 . Cross-talk between LC and surrounding keratinocytes, coupled with their ability to cross-present antigens expressed by other cells to skin resident and infiltrating T lymphocytes, defines the major role of LC in skin immunity and allows them to initiate efficient adaptive immune responses in the context of skin infection [25] [26] [27] . However, little is known about the genomic mechanisms which programme LC functions in homeostasis and inflammation and how epidermal-derived signals modify such programming.
Like macrophages, LCs originate from yolk-sac progenitors and populate the epidermis during embryonic life. However, functionally, they are more similar to conventional DCs in their ability to efficiently present and cross-present antigens to prime T cell responses 28, 29 .
Our recent research suggests that even though LCs are among the most efficient antigen presenting cells, their transcriptional networks are distinct from those of both macrophages and DCs 22, 30 , warranting deeper analyses. Molecular studies and comparative transcriptome analysis further highlight the fundamental differences in gene regulatory networks between LCs and conventional DCs 30, 31 . In recent years, in all DC subtypes studied, two members of the interferon regulatory factor (IRF) family, IRF-4 and IRF-8, have emerged as key players in DC development and function [32] [33] [34] [35] . IRF4 and IRF8 are critical for all aspects of DC biology, controlling a wide range of functions. These include induction of innate responses elicited via pattern recognition receptors TLR, NOD, and RIG during viral and bacterial infection [36] [37] [38] , cell activation, and efficient antigen uptake, presentation and cross-presentation 23, 33, 39 , migration and tolerance induction 39, 40 . Interestingly, it has been postulated that the ability of murine DC subsets to efficiently activate CD8 and CD4 T cells, depending on the presentation of antigen in the context of MHC class I and II, is determined by the relative expression of IRF8 and IRF4, respectively 33 . Furthermore, the function of conventional DCs, excelling at crosspresentation of tumor cell-associated antigens, is critically dependent on BATF3/IRF8 complexes 41, 42 . Genome-wide expression analysis reveals similarities between human LCs and cross-priming murine dendritic cells 29, 30 . LC development has been shown to be IRF4 and IRF8-independent in both murine and human systems 31, 43, 44 . Crucially, it remains to be determined if IRF4 and/or IRF8 regulate the genomic programming and functions of human epidermal LCs.
Here we show that human LCs enhance their ability to cross-present antigens during their migration out of the epidermis. This is accompanied by the induction of the transcription factor IRF4 in the absence of IRF8. Furthermore, expression of IRF4 in human LCs is correlated by scRNA-seq with genes involved in ubiquitin-dependent protein degradation. Priming of CD8 T cell responses by LCs is further stimulated by TNF-α signalling. Chromatin profiling before and after TNF-α stimulation reveals enrichment of EICE and AICE transcription factor binding motifs in regulatory regions of antigen-presentation gene modules. These composite motifs can be recognized by IRF4 in conjunction with PU.1 and BATF3, respectively, also expressed in these cells. Thus, the genomic programming of LCs for cross-presentation is independent of IRF8 and instead appears to utilize IRF4 in combination with PU.1 and BATF3, thereby differentiating LC from conventional dendritic cells.
Results

Migration and TNF-α signalling induce antigen cross-presentation and priming of CD8 T cell responses by human skin LCs
To enable the analysis of the genomic programming of primary human LCs, we utilized established protocols for isolating highly pure populations of viable and functional LCs from the epidermis, ( 2,22 , Figure 1a -c, Supplementary data Figure S1 ). In agreement with our earlier findings and those of others 2, 9, 45 , human LC after migrating from the epidermis uniformly expressed high levels of CD1a, CD207 and HLA-DR (Figure 1b , Supplementary data Figure S1 ).
Such migrated LCs are able to take up and present antigens to CD8 and CD4 T cells, activating the latter ( 2,23 , Supplementary data Figure S1 ). These LCs express high levels of MHC class I and II complexes on their surface. Notably, migration from the epidermis increases LC activation status, as assessed by enhanced expression of co-stimulatory molecules: CD40, CD70, CD80, CD86 (Figure 1c) . To analyse the effects of migration as well as TNF-α signalling on LC cross-priming we used an established model for antigen cross-presentation 2 . Steady state and migrated LCs were pulsed with a 30 amino acid peptide, comprising a 9 amino acid HLA-A2 restricted GLC epitope from Epstein Barr Virus protein BMLF and stimulated with TNF-α. We have previously demonstrated that the cross-presentation of the GLC epitope to antigen-specific CD8 T cells was critically dependent on the ability of LCs to take up and actively process the 30AA peptide for presentation 2 . LC migration from the skin induced their ability to cross-present antigens as measured by IFN-γ release from a GLC peptide-specific HLA-A2 CD8 T cell line (Figure 1d , Supplementary data Figure S1 ). TNF-α signalling further enhanced the ability of migrated LCs to cross-present the same antigen (Figure 1e ). We note that in the presence or absence of TNF-α, cells fixed with glutaraldehyde prior to antigen pulsing did not activate cognate CD8 T cells. In contrast, fixation did not affect presentation of a short peptide, which could be externally loaded onto the MHC molecules. Furthermore, fixing LC post pulsing but before co-culture with T lymphocytes, reduced their ability to activate CD8 T cells 2 . This is consistent with the inhibition of intracellular protein trafficking and antigen processing by glutaraldehye fixation. Thus, LC migration upregulates costimulatory molecules and their antigen cross-presentation capabilities, the latter can be further augmented by TNF-α signalling.
Human skin LCs are transcriptionally programmed to efficiently cross-present antigens
To gain insights into the genomic programming of migrated LCs we analysed their transcriptome using bulk RNA-sequencing. The antigen processing and presentation genes were quantitatively amongst the highest expressed genes in migrated LCs and are therefore designated as the core LC transcriptional programme (Figure 2a , Supplementary data Figure   S2 ). This confirmed and extended our previous analysis using DNA microarrays 22 . We next compared the expression of genes in migrated LCs with previously reported signatures of cross-presenting DCs, including those in the Reactome database and reported by Artyomov and colleagues 29 . These were compiled into an "antigen cross-presenting" molecular signature (Supplementary data Table 1 , Supplementary Figure S2 ) and "antigen processing" signature ( Figure 2b ). In agreement with previously published data 29 , the gene signature encoding antigen processing and presentation in different populations of cross-presenting human skin and blood derived DCs was recapitulated in human LCs, suggesting the existence of a shared transcriptional programme (Figure 2b , Supplementary data, Figure S2 ). While 57 genes shared between all three subsets encoded for proteasome structure (41 genes, FDR p = 7.32 -93 ), protein catabolic process, (FDR p = 8.164 -100 ) and antigen presentation to class I (FDR p = 1.324 -95 ), 287 genes shared between LCs and other cross-presenting DCs were involved in metabolic processes (FDR p = 5.39 -19 ), including NADH dehydrogenase activity FDR p = 2.723 -11 ). Notably, the core LC genomic programme was accompanied by high levels of expression of genes encoding ubiquitin protease activity (Figure 2a) . Accordingly, 64/66 genes shared between LCs and the antigen processing signature encoded protein ubiquitination components (FDR p = 1.340 -83 ).
Single cell transcriptome profiling reveals correlation between metabolism and antigen processing gene modules in human LCs
Next, we used scRNA-seq to analyse the transcriptomes of migrated single cells isolated from human epidermis, a population highly enriched in LCs (>80% of CD1a+, HLADR+ cells, Supplementary data Figure S3 ). Seurat analysis 46 clearly identified two main cell subsets, confirming LC identity for 138 out of 150 cells (92%, p = 1.163 -21 ), and assigning the remaining population as melanocytes (p=9.624 -9 ) (Supplementary data Figure S3 ). Interestingly, as identified by Seurat analysis, the main genes defining the LC cluster features were those encoding antigen presenting molecules HLADR and CD74, together with TMSB4X, which is involved in actin polymerisation, cell motility and cytoskeleton re-organisation.
We next mapped single cell LC transcriptomes onto the recently described 10 subpopulations of human blood monocytes and DCs, (GSE94820), 47 ), using CellHarmony 48 This is in agreement with the potent ability of both cDC2 and 3 to prime cytotoxic CD8 lymphocytes 47 .
Iterative clustering and guide-gene selection 50 Figure S4f ). Thus, antigen cross-presentation by human LCs appears to be IRF8
independent. This possibility was tested directly with murine LCs isolated from IRF8 knockout mice 54 . IRF8-deficient LCs were able to cross-present the SIINFEKL epitope from the ovalbumin protein to OT1 cells, equivalently to their wildtype counterparts (Supplementary data Figure S4g -h). These results with murine IRF8 KO LCs are consistent with the findings with human LCs and demonstrate that antigen cross-presentation by LCs is indeed independent of IRF8. Instead, the results strongly suggest that human LCs depend on IRF4 along with PU.1 and BATF3 for programming expression of their cross-presentation genes.
IRF4 expression is correlated with the antigen cross-presentation programme in single cell
LC transcriptomes
Having found that IRF4 is strongly induced when LCs migrate from the epidermis (Figure 4 a,b), a process associated with their enhanced antigen cross-presentation (Figure 1c Table S3 ). It is therefore highly conceivable that IRF4, up-regulated during LC migration from the epidermis, specifically regulates expression of genes involved in protein ubiquitination in LCs, contributing to the ability of these cells to efficiently cross-present antigens.
Enrichment of IRF composite elements in chromatin implicates IRF4-PU.1 and IRF4-BATF3 complexes in LC genomic programme for antigen cross-presentation
To uncover additional genes whose regulated expression could enhance the ability of migrated LCs for antigen cross-presentation, we performed RNA-seq in the absence of and with TNF-α stimulation for 2 or 24 hours. As shown above, TNF-α signalling leads to enhancement of LC antigen cross-presentation ( Figure 1e) . Although, the overall transcriptomic network remained relatively stable under these activation conditions, 1,156 genes were significantly differentially regulated by TNF-α (EdgeR, FDR<0.05, |LogFC|>1). Table S6 ). In agreement with our microarray analysis 22 To explore if IRF4 along with its ETS and AP-1 family partners, PU.1 and BATF3 could be directly controlling the expression of antigen cross-presentation genes in human LCs, we performed genome-wide chromatin profiling and transcription factor motif enrichment analyses. This approach enables the inference of transcriptional regulatory sequences and the transcription factors that are acting to control gene activity in distinct cell types and cell states 39, 57 . Notably, tri-methylation at lysine 4 of histone 3 (H3K4Me3) marks active promoters 58 , whereas acetylation of lysine 27 of histone 3 (H3K27Ac) marks active transcriptional enhancers; the latter have been postulated to be the primary determinants of tissue-specific gene expression 59, 60 . Thus, we performed ChIP-seq to analyse the genome-wide landscape of H3K4Me3 and H3K27Ac in migrated and TNF-α-activated LCs. Three independent samples of human migrated LCs exhibited a highly conserved histone modification landscape across the genome with 95% of H3K4Me3 marks in the same regions (Supplementary Table S4 ). Analysis of H3K27 acetylation peaks in the same LC preparations showed 78% to be shared across all three samples (Supplementary data Table S5 ). Of 13,402 H3K4Me3 peaks common for steady state LCs (11,665 unique genes), over 92% of the H3K4Me3 peaks were mapped to promoter regions (Supplementary data Table S4 ). In contrast, while 62% of H3K27Ac peaks were positioned either within the promoter region or upstream, a significant proportion of these peaks were distributed in other areas of the genome (Supplementary data Table S5 ). This distribution was expected for intergenic or intronic enhancers that function at large distances from the promoters on which they act.
Focusing the analysis on genes associated with immune function (InnateDB:
Immunome collection, 61 ), we identified 290 immune genes with active (H3K4Me3) promoters. These were highly enriched in genes encoding receptor binding and activation (in particular able to respond to TNF-α cytokine family signalling (FDR p= 1.2x10E-12), and genes This was in marked contrast to genes involved in antigen presentation. To analyse whether genomic programming of human steady-state LCs was similar to other known cell types including monocytes, DCs and macrophages, we compared our ChiP-seq profiles to a large collection of publically available genomics datasets (see Methods). Surprisingly, the chromatin landscape of steady-state migrated LCs was strikingly similar to that of macrophages and CD14+ monocytes, and significantly less strongly correlated with that of dendritic cells (Supplementary Table S6 Moreover, TNF-α signalling enhanced H3K27Ac levels in over 50% of genes (Supplementary data Figure S6 e,g). In line with the transcriptome changes, genes with enhanced H3K27Ac marks at 2h encoded innate immune processes including leukocyte activation (FDR p-value = 2x10E-19) and co-stimulation (FDR p-value = 7.99x10E-16). A significant proportion of genes (286) within this programme was associated with ubiquitin-mediated proteolysis, highlighting the importance of this process for LC function (FDR p = 3.8 x 10E-85). In contrast, genes involved in cell cycle and motility were characterised by reduced histone acetylation marks.
Consistent with their unstimulated profile, and the lack/low levels of mRNA, many proinflammatory cytokine loci (such as IL1b, IL12a), classically associated with DC immune activation, were characterised by paucity of histone marks upon stimulation with TNF-α, both with regard to H3K4Me3 and H3K27Ac. It is worth noting that the majority of histone marks induced by TNF-α signalling were readily detected prior to activation (Figure 6c,d) , suggesting that the migrated LCs were pre-programmed for rapid immune activation from a genomic standpoint.
To test if IRF4 along with its ETS and AP-1 family partners, PU.1 and BATF3 could be directly controlling the expression of antigen cross-presentation genes in human LCs, we performed transcription factor (TF) motif enrichment analyses. There was extremely high enrichment of the known composite IRF-binding sequences 35 Thus, transcription and chromatin profiling coupled with TF motif analysis strong suggests that IRF4 in conjunction with PU.1 and BATF3, binding to EICE and AICE motifs, respectively, program the expression of a large set genes in human LCs that are involved in antigen crosspresentation.
Discussion
Since their discovery by Paul Langerhans in 1864, LCs have been puzzling scientists. Despite being the longest studied antigen presenting cell population, and being considered the stereotypical "dendritic cells", their place in the innate immune cell spectrum and developmental programming remain elusive. This conundrum is in part caused by the difficulties in studying LC, arising from paucity of in vitro models, controversy around defining a suitable LC progenitor, and the differences between human and murine skin immunology 62 . To address these challenges in the analysis of primary human LCs, we utilized an integrative systems immunology approach, combining transcriptome analysis at the population and single cell levels with profiling of the chromatin landscapes ultimately coupling these genomic profiles with LC phenotypic and functional characteristics. While our investigations are restricted by the availability of the cells and the limitations of experimental models, we believe that our approach offers the opportunity of addressing some of the key molecular questions in primary human LCs, enabling us to propose a plausible model for regulation of LC activation. Our extensive transcriptomic and epigenomic analyses of primary human skinderived LCs reveals three striking features: (i) The pre-programming and relative stability of the LC chromatin landscape and transcriptome (ii) the importance of migration from the epidermis for activation of the LC transcriptome programme and (iii) the likely dependence of LC migration and function, in particular their ability to cross-present antigens, on a major immune transcriptional regulator IRF4 rather than its paralog IRF8. All three features are likely to be interconnected, and at least in part dictated by the localisation of LCs in the epidermis 63 .
By profiling the H3K4Me3 and H3K27Ac histone modifications across the LC genome, we were able to construct the chromatin landscape of human migrated LCs for the first time, and document that their transcriptomic programme encoding antigen presentation genes is poised for efficient expression during, or before their migration from the epidermis. TNF-α, a pro-inflammatory signal produced in the skin plays a critical role in activating LC emigration from the epidermis, hence, in inducing LC immunogenic function and ability to present antigens. Stimulation with TNF-α, significantly enhanced the pre-existing transcriptional programme, further confirming that the LCs are fully committed for efficient antigen presentation and cross-presentation. Such genomic programming, realised at the level of transcriptional enhancers, could be both developmentally and environmentally specified. The latter, termed "trained immunity", has been recently documented in murine myeloid cell 71, 72 , while other members of the MARCH family enhance phagocytosis and antigen presentation through ubiquitination of MHC molecules 70 or facilitate entry of MHC molecules to the endoplasmic reticulum (ER) 73 . Since abrogation of polyubiquitination strongly reduces the epitope presentation from ER-processed antigens 74 , it is conceivable that increase of polyubiquitination expands the spectrum of epitopes in activated. The notable lack of IRF8 expression in LCs, consistent with inactive chromatin at the IRF8 locus, distinguishes LCs from both macrophages and DCs and likely contributes to their discrete role in epidermal homeostasis. Independence of LCs from IRF8 could represent a mechanism for their plasticity, enabling them to be adapted to their environmental niche.
IRF8 has been shown to regulate production of pro-inflammatory cytokines in DCs 75, 76 , and macrophages, the latter contributing to chronic inflammation 77 . We propose that by utilising IRF4 rather than IRF8, LCs uncouple the cross-presentation of antigens from production of pro-inflammatory mediators, and thus prevent excessive inflammatory responses and promote epidermal homeostasis.
The epidermis forms a unique environmental niche, constantly exposed to insults from the outside world and to interactions with symbiotic and pathogenic microbiota.
Inhabiting this niche, LC need to react rapidly to any changes and hence require highly efficient transcriptomic networks in order to initiate precise and efficient adaptive immune responses. In contrast, excessive pro-inflammatory signals need to be limited, in order to preserve tissue homeostasis. At the same time, due to their external localisation, LCs are constantly exposed to environmental insults, and thus need to develop resilience to DNA damage and re-structuring, as described in the "access-repair-restore" model 78 . Relative stability of LC transcriptomic networks and chromatin landscape very efficiently meets the criteria required, preventing both excessive inflammatory signalling and accumulation of molecular alterations due to the interactions with environment. Cross-talk with keratinocytes has been shown to be fundamental for LC development and keratinocyte-derived TGF-β and BMP7 have long been recognised as critical for LC development both in vivo and in vitro 15, 79, 80 . individuals were isolated by Ficoll-Hypaque density gradient centrifugation and co-cultured with 40 μM EBV peptide for 12 days in complete medium supplemented with 1% sodium pyruvate (Gibco, UK) plus 10% human serum (Sigma,UK). IL-2 (100 IU/ml, Peprotech, UK) was added every 3 days. IL-2 was removed from the culture for 24 hours prior to testing in ELISpot.
For ELISpot assays, TNF-α matured and washed EBV peptide pulsed LCs (1x10 3 cells) were cocultured with GLC peptide-specific T cells (5x10 4 
RNA-seq
RNA was isolated using RNeasy mini kit (Qiagen) as per the manufacturer's protocol. RNA concentration and integrity was determined with an Agilent Bioanalyser (Agilent Technologies, Santa Clara, CA). All the samples had a RNA integrity number of 7.0 or above and were taken forward for labelling. RNA-seq libraries were generated from 300 ng total RNA with an RNA Sample Prep Kit (Illumina) according to a standard protocol. The libraries were sequenced with Illumina HiSeq2500 in the DNA sequencing core of the Cincinnati Children's Hospital Medical Center. Each sample was used to generate 2 × 10 7 reads with 75-base pair paired-end sequencing.
ChIP-seq
Purified migrated LCs were fixed with 1% formaldehyde for 15 min and the reaction quenched with 0.125 M glycine. Chromatin was isolated by the addition of lysis buffer, followed by disruption with a Dounce homogenizer. Lysates were sonicated and the DNA sheared to an average length of 100-200 bp (Covaris). Genomic DNA (Input) was prepared by treating aliquots of chromatin with RNase, proteinase K and heat to remove crosslinks, followed by ethanol precipitation. Pellets were resuspended and the resulting DNA was quantified on a NanoDrop spectrophotometer. Extrapolation to the original chromatin volume allowed quantitation of the total chromatin yield. Genomic DNA regions of interest were isolated using 2.8 μg of antibody against H3K27Ac or H3K4Me3 84 . Complexes were washed, eluted from the beads with SDS buffer, and subjected to RNase and proteinase K treatment.
Crosslinks were reversed by incubation overnight at 65 °C, and ChIP DNA was purified by phenol-chloroform extraction and ethanol precipitation. Illumina sequencing libraries were prepared from the ChIP and input DNAs by the standard consecutive enzymatic steps of endpolishing, dA-addition, and adaptor ligation using Truplex TM -FD prep kit (Rubicon Genomics, USA). After a final PCR amplification step, the resulting DNA libraries were quantified using Qubid and 75 nucleotide single-end reads were sequenced Illumina HiSeq2500 in the DNA sequencing core of the Cincinnati Children's Hospital Medical Center.
Drop-seq
Highly purified human LCs (> 80% of CD1a+HLADR+) were unbanked from cryo-storage, and processed on ice to enable the co-encapsulation of single cells with genetically-encoded beads (Drop-seq, 85 ). Monodisperse droplets at 1 nl in size were generated using the microfluidic devices fabricated in the Centre for Hybrid Biodevices, University of Southampton. To achieve single cell/single bead encapsulation barcoded Bead SeqB 
Bulk RNA-seq data analysis
Quality control for FASTQ files with raw sequence data was done using FASTQC tool [FastQC: a quality control tool for high throughput sequence data. Available online at:
http://www.bioinformatics.babraham.ac.uk/projects/fastqc ] Adapter sequences and low quality reads were trimmed using Trimmomatic 86 . High-quality reads were mapped to the human genome (hg19) using TopHat (version 2.0.9, 87 ) and, following the removal of multimapping reads, converted to gene specific read counts for annotated genes using HTSeq-count (version 0.5.4) 88 . Raw counts from RNA-Seq were processed in Bioconductor package EdgeR 89 , variance was estimated and size factor normalized using TMM. Genes with minimum 2 reads at minimum 50% samples were included in the downstream analyses.
Differentially expressed genes (DEG) we identified applying significance threshold FDR p<0.05, |LogFC|>1. Normalised reads from DEG were taken for transcript-to-transcript coexpression analysis (BioLayout Express 3D , 90 . FPKMs were estimated using Cufflinks package 87 . Gene ontology analysis was done using ToppGene on-line tool 91 .
scRNA-seq data analysis
Digital gene expression data was generated for the 150 STAMPs following the pipeline established in the McCarrol lab 85 . Samples were de-multiplexed with bcl2fastq tool from Illumina, and tag bam files with read sequence extended were processed to differentiate molecular barcodes, cell barcodes and genome reads. Reads with low quality bar codes were removed, and the unpaired reads were aligned with STAR. To create a matrix of digital gene expression data, the total number of unique UMI sequences was counted for each transcript for a given cell 85 . Highly expressed genes and high-quality cells were selected through filtering by both the mean count of each gene across all cells and also the mean count of all genes expressed in a single cell (mixture model filtering). This reduced the matrix from 15200 genes and 150 cells to 9075 genes and 118 cells. To investigate cell-to-cell variability in gene expression Hierarchical clustering (clust=ward.D2, dist = canberra) was applied. Transcript-totranscript correlation was assessed using BioLayout Express 3D 90 , corrplot and hmisc packages in R environment 92 . Differentially expressed genes were identified through comparing mean gene expression values between clusters of interest. Genes with a |logFC| >1 in expression between comparisons were submitted to gene ontology analysis in Toppgene (adj. p-value <0.05) to characterise the specific biological processes and pathways associated with each subpopulation. To assess gene expression signatures and pathway activation, a nonparametric and unsupervised software algorithm called GSVA software in the R package with the RNA-seq mode was used 93 . We included a set of marker genes from monocytes and DC from Villani et al. as a reference set 47 . Over-representation analysis was performed using the hypergeometric test. The results were plotted as a heat map using hierarchical clustering.
ChIP-seq data analysis
ChIP-seq data analysis was performed using pipelines implemented in the BioWardrobe suite 94 BAM-formatted hg19 aligned ChIPseq reads were used for peak calling MACS2 (version 2.1.1. 95 was used to estimate fragment size, identify and annotate peaks. Changes in histone modification profiles were assessed with MAnorm algorithm implemented in BioWardrobe.
ChiP-seq profiles at a distance -3000bp -+3000bp from TSS were generated using ChIPseeker package in R. Common regions with histone modification were identified using findoverlaps function, DiffBind package (R environment.
Transcription factor binding site motif enrichment analysis
We performed TF motif enrichment analysis on ChIP-seq peak sets using the HOMER sortware package 96 . HOMER calculates the statistical enrichment in a set of input DNA sequences (here, ChIP-seq peak sequences) for a large set of position weight matrix (PWM) TF binding models. Subsequently, putative binding sites for enriched motifs (EICE, AICE, and ISRE) were identified in the H3K27ac T0 dataset using custom scripts encoding the standard log likelihood PWM scoring function 97 . DNA sequences scoring at least 70% of the best possible loglikelihood score were recorded as putative binding sites.
Intersection of ChIP-seq peaks with available public functional genomics datasets
To identify transcription factor binding events and other epigenetic marks that overlap with our ChIP-seq data, we used our Regulatory Element Locus Intersector (RELI) computational method 98 , which overlaps a set of genomic locations (e.g., peaks from a ChIP-seq experiment)
with a large collection of functional genomics datasets. We created a library of ~5,000 datasets by compiling data (ChIP-seq for TFs and histone marks, DNase-seq, ATAC-seq, etc.) from a variety of sources, including ENCODE 99 , Cistrome 100 , PAZAR 101 , Re-Map 102 , and Roadmap Epigenomics 103 . As input, RELI takes a set of genomic loci (e.g., H3K27ac ChIP-seq peaks at T0). These loci are systematically intersected with each functional genomics dataset, and the number of input regions overlapping each dataset by at least one base are counted.
Next, a p-value describing the significance of this overlap is estimated using a simulationbased procedure. To this end, a 'negative set' is created for comparison to the input set, which is created by compiling all regions of open chromatin in the genome (i.e., the union of all available human DNAse-seq, ATAC-seq, and FAIRE-seq datasets). A distribution of expected overlap values is then created from 2,000 iterations of randomly sampling from the negative set, each time choosing a set of negative examples that match the input set in terms of the total number of genomic loci and the length of each locus. The distribution of the expected overlap values is used to generate a Z-score and corresponding p-value estimating the significance of the observed number of input regions that overlap each data set. Collectively, this procedure controls for the count and sizes of the input loci, and the count and sizes of each individual dataset in the library.
Accession codes: Sequencing data for RNA-seq, scRNA-seq and ChiP-seq is stored in Gene Expression Omnibus database, submission number GSE120386. 150 single migrated epidermal cells highly enriched in LC were subjected to Drop-seq encapsulation and single cell RNA-sequencing. Reads were aligned against human reference genome (hg19) using STAR aligner (v2.5.0a), then sorted/converted/merged to a BAM with a tag "GE" onto reads for data extraction. The DigitalExpression program (Dropseq-tools v1.0) performed digital counting (DGE) of the mRNA transcripts (unique molecular identifiers to avoid double counting reads/PCR duplicates) and created a DGE matrix (one measurement per gene per cell). Cells expressing less than 300 or more than 3,000 genes were excluded from further analysis. Digital gene expression matrix was subjected to Seurat analytical pipeline, to identify cell subpopulations and cluster defining markers. a) Purity of migrated epidermal cells subjected to single cell analysis, 83% cells were CD1a/HLA-DR positive, expressing classical migrated LCs phenotype, b) tSNE plot identifying contamination of epidermal LCs (red) with melanocytes (blue) c) Expression of selected cluster defining markers identified with Seurat analysis across cell population. d) scRNA_seq LC data was normalized using SCnorm 106 in R version 3.5.1; Projection onto a reference set of newly classified dendritic cells 47 was carried out using Gene Set Variation Analysis (GSVA) 93 based on enrichment score. The heatmap shows the GSVA enrichment score for each LC transcriptome. e)
The heatmap shows the Pearson correlation coefficient for each LC transcriptome. state LCs (CD1a/CD207 high ). Gates set using isotype controls. Data representative of 8 independent skin donors b) Flow cytometry analysis of intranuclear IRF8 protein expression in migrated and steadystate LCs (CD1a/CD207 high ). Gates set using isotype controls. Data representative of 3 independent skin donors c) Flow cytometry analysis of intranuclear PU.1 protein expression in migrated and steadystate LCs (CD1a/CD207 high ). Gates set using isotype controls. Data show an independent experiment (n=1) d) Flow cytometry analysis of intranuclear BATF3 protein expression in migrated and steady-state LCs (CD1a/CD207 high ). Gates set using isotype controls. Data representative of 8 independent skin donors. e) Flow cytometry analysis of intranuclear cJUN protein expression in migrated and steadystate LCs (CD1a/CD207 high ). Gates set using isotype controls. Data representative of 2 independent skin donors. f) Flow cytometry analysis of intranuclear IRF8 protein expression during a timecourse of stimulation with TNF-α in migrated LCs (CD1a/CD207 high ). Gates set using isotype controls. Data representative of 2 independent skin donors. g) Wild type (wt) and IRF8-/-LCs were isolated from ears and tails from 3 mice/type maintained on C57Bl/6 background. Flow cytometry analysis of intranuclear IRF8 and IRF4 protein expression. n=1, LCs pooled from 3 mice. h) IFN-γ production by OTI line stimulated with OVA-pulsed wild type (wt) and IRF8-/-LCs. Table S1 : Antigen presentation and cross-presentation signatures Table S2 : Correlation of antigen processing signature and TF expression in scRNA Table S3 : Genes correlated with IRF4 in scRNA-seq analysis Table S4 : Consensus peaks in H3K4Me3 ChIP-seq in steady-state migrated human LCs Table S5 : Consensus peaks in H3K27Ac ChIP-seq in steady-state migrated human LCs Table S6 : GO enrichment in transcript-to-transcript clustering of LC transcriptome over the 24h stimulation with TNF-α Table S7 : Overlaps between chromatin landscape in human migrated LCs and publically available datasets Table S8 : Transcription factor motif enrichment in migrated human LCs
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